Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
2024 Standout
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
2022 Standout
Works of Semra Bilaçeroğlu being referenced
Tissue Plasminogen Activator Combined With Human Recombinant Deoxyribonuclease Is Effective Therapy for Empyema in a Rabbit Model
2006
Prednisolone: a beneficial and safe adjunct to antituberculosis treatment? A randomized controlled trial.
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Semra Bilaçeroğlu | 532 | 201 | 59 | 84 | 44 | 652 | |
| Georgie A. Eapen | 490 | 156 | 29 | 72 | 44 | 650 | |
| Jonas Yserbyt | 641 | 243 | 29 | 174 | 52 | 829 | |
| Stephan Eggeling | 390 | 96 | 34 | 55 | 33 | 599 | |
| Marie A. Capitanio | 275 | 359 | 62 | 36 | 44 | 779 | |
| Alex Chee | 548 | 214 | 24 | 104 | 56 | 715 | |
| Tan-Lucien Mohammed | 339 | 141 | 50 | 35 | 55 | 699 | |
| Jack L. Westcott | 521 | 253 | 19 | 61 | 38 | 679 | |
| Stavros Anevlavis | 470 | 96 | 35 | 122 | 39 | 666 | |
| Ignasi García-Olivé | 359 | 106 | 137 | 47 | 56 | 589 | |
| Pedro Rodríguez | 358 | 301 | 42 | 78 | 66 | 645 |
All Works
Login with ORCID to disown or claim papers
Loading papers...